CY1117502T1 - Αντι ceacam1 αντισωματα και μεθοδοι χρησης αυτων - Google Patents

Αντι ceacam1 αντισωματα και μεθοδοι χρησης αυτων

Info

Publication number
CY1117502T1
CY1117502T1 CY20151101082T CY151101082T CY1117502T1 CY 1117502 T1 CY1117502 T1 CY 1117502T1 CY 20151101082 T CY20151101082 T CY 20151101082T CY 151101082 T CY151101082 T CY 151101082T CY 1117502 T1 CY1117502 T1 CY 1117502T1
Authority
CY
Cyprus
Prior art keywords
methods
ceacam1 antibodies
antibodies
ceacam1
disclosed
Prior art date
Application number
CY20151101082T
Other languages
English (en)
Inventor
Gal Markel
Rona Ortenberg
Jacob Schachter
Original Assignee
Tel Hashomer Medical Research Infrastructure And Services Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10721207.8A external-priority patent/EP2424896B1/en
Application filed by Tel Hashomer Medical Research Infrastructure And Services Ltd. filed Critical Tel Hashomer Medical Research Infrastructure And Services Ltd.
Publication of CY1117502T1 publication Critical patent/CY1117502T1/el

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Αποκαλύπτεται ένα κύτταρο υβριδώματος το οποίο έχει αποτεθεί στην ATCC με Αριθμό Προσθήκης ΡΤΑ-9974. Επίσης παρέχονται Αντισώματα και μεθόδοι χρήσης αυτών.
CY20151101082T 2009-04-30 2015-11-27 Αντι ceacam1 αντισωματα και μεθοδοι χρησης αυτων CY1117502T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21304009A 2009-04-30 2009-04-30
EP10721207.8A EP2424896B1 (en) 2009-04-30 2010-04-29 Anti ceacam1 antibodies and methods of using same

Publications (1)

Publication Number Publication Date
CY1117502T1 true CY1117502T1 (el) 2017-04-26

Family

ID=58606620

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151101082T CY1117502T1 (el) 2009-04-30 2015-11-27 Αντι ceacam1 αντισωματα και μεθοδοι χρησης αυτων

Country Status (1)

Country Link
CY (1) CY1117502T1 (el)

Similar Documents

Publication Publication Date Title
CL2019002036A1 (es) Anticuerpo contra bcma y su uso.
CY1121862T1 (el) Αντισωματα anti-phf-tau και χρησεις αυτων
CL2018000263A1 (es) Constructos de anticuerpo biespecificos que se unen a egfrviii y cd3.
CL2018000270A1 (es) Constructos de anticuerpo para cd70 y cd3.
CL2018000269A1 (es) Constructos de anticuerpo para flt3 y cd3
CO6720984A2 (es) Anticuerpos anti-mesotelina e inmunoconjugados
ECSP10010438A (es) ANTICUERPOS ANTI-CD79b E INMUNOCONJUGADOS Y METODOS DE USO
PH12014501758B1 (en) Cd47 antibodies and methods of use thereof
CL2015000582A1 (es) Anticuerpos anti-mcam y métodos asociados de uso
PE20151926A1 (es) Anticuerpos de receptores de antitransferrina y metodos de uso
CO6721041A2 (es) Anticuerpo anti-pcsk9 y métodos de uso
UY34411A (es) Inmunoenlazantes dirigidos contra esclerostina
TR201910320T4 (tr) Karaciğer organoidi, kullanımları ve elde edilmesine yönelik kültür yöntemi.
CO6771458A2 (es) Conjugados de anticuerpo-fármaco
GT201200096A (es) Anticuerpos monoclonales
BR112012024049A2 (pt) interferência de rna em indicações dérmicas e fibróticas
NZ702680A (en) Anti-gd2 antibodies
CR20110576A (es) Anticuerpos anti-egfl7 humanizados y métodos de uso de los mismos
EP2566890A4 (en) ANTI-PAI-1 ANTIBODIES AND METHOD FOR THEIR USE
GB2482536B (en) Expression of antibody or a fragment thereof in lactobacillus
CO6680644A2 (es) Polipétidos de ralaxina modificados y sus usos
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
MX340555B (es) Anticuerpos contra il-18r1 y usos de los mismos.
MX336323B (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
CY1117502T1 (el) Αντι ceacam1 αντισωματα και μεθοδοι χρησης αυτων